「Meeting Highlights From The Committee For Medicinal Products For Human Use CHMP 12-15 December 2025」の版間の差分

ナビゲーションに移動 検索に移動
ページの作成:「<br>The committee advisable to extend using original Spikevax vaccine and Spikevax bivalent Original/Omicron BA.1 as a booster dose in youngsters aged 6 to 11 years. The…」
(ページの作成:「<br>The committee advisable to extend using original Spikevax vaccine and Spikevax bivalent Original/Omicron BA.1 as a booster dose in youngsters aged 6 to 11 years. The…」)
 
(相違点なし)
匿名利用者

案内メニュー